Imunon receives Nasdaq delisting notice for bid price and equity non-compliance

Imunon, Inc.

Delisting determination letter received May 28, 2025 for failure to regain $1.00 minimum bid price by May 27, 2025.
Company not eligible for additional extension due to not meeting $5M minimum stockholders' equity requirement.
Separate deficiency notice on May 19, 2025 for non-compliance with minimum stockholders' equity under Rule 5550(b)(1).
Company will request a hearing by June 4, 2025 to appeal; trading suspension stayed pending hearing decision.
Plans to propose a reverse stock split to regain compliance, subject to board and stockholder approval.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.